top of page
LATEST 3DBT NEWS
3D Bio-Tissues’ ETSYL Enters Global Luxury Skincare Partnership
3D Bio-Tissues is pleased to announce a major new commercial milestone for ETSYL®, its proprietary bioactive peptide originally developed through the company’s tissue engineering research. BSF Enterprise PLC has signed Heads of Terms with SCHAKAU Managementberatung GmbH for the worldwide exclusive commercialisation, distribution and licensing of ETSYL® across the cosmetics, skincare, dermocosmetics and luxury beauty sectors. For 3D Bio-Tissues, the agreement represents an imp
4 days ago2 min read
3DBT products now available on CellBase
The 3DBT portfolio available via CellBase includes: CytoBoost™ A chemically defined, xeno-free range of media additives designed to replicate macromolecular crowding in native in vivo environments, supporting improved cell performance, consistency and reproducibility across a wide range of cell culture applications. The CytoBoost™ range includes: • CytoBoost™ PERFORM : supports robust day-to-day cell culture by enhancing cell health and functional performance across routine r
Jan 302 min read
3D Bio-Tissues Partners with SeaWith to Reduce Cultivated Meat Production Costs
SeaWith is incorporating City-Mix®, 3DBT’s proprietary macromolecular crowder media additive, into its cultivated beef development programme. The use of City-Mix® is designed to enhance cell growth efficiency while reducing overall media consumption, a key cost driver in cultivated meat production.
Jan 222 min read
When Organoids Flatline: Thawing is Their Toughest Test
Organoids are extraordinary — miniature organs, or engineered tissues, built from cells that know exactly what to do. They fold, layer, and organise themselves into complex, living systems that mirror real tissues with astonishing precision.
Oct 31, 20252 min read
bottom of page